US2014350248A1PendingUtilityA1

Chemical entities and therapeutic uses thereof

57
Assignee: INTELLIKINE LLCPriority: Oct 4, 2007Filed: Dec 23, 2013Published: Nov 27, 2014
Est. expiryOct 4, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 37/00A61P 5/00A61P 35/00A61P 9/00A61P 25/00A61P 29/00A61P 3/00A61P 11/00A61P 19/08C07D 471/04C07D 401/12C07D 403/04C07D 239/94A61K 31/517C07D 401/14C07D 239/84C07D 239/42C07D 471/14C07D 401/04Y02A50/30
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Certain chemical entities that modulate PI3 kinase activity, and chemical entities, pharmaceutical compositions, and methods of treatments of diseases and conditions associated with PB kinase activity are described.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula I 
       
         
           
           
               
               
           
         
         and pharmaceutically acceptable salts thereof, wherein 
         W 1  is CR 6 , CHR 6 , NR 6 , or N; 
         W 2  is CR 7 , N, or NR 7 ; 
         W 3  is CR 2 , CHR 2 , N, or NR 2 ; 
         W 4  is CR 11  or N; 
         W 5  is C(O), CHR 3 , or CR 3 ; and no more than two adjacent ring atoms are N or NR 7 ; 
         R 1  is hydrogen, amino, alkyl, alkoxy, aryl, heteroaryl, or cyano; 
         R 2  is hydrogen, halo, amino, alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl or X; 
         R 3  is hydrogen, amino, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or X; 
         R 4  is hydrogen and R 5  is hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, amino, alkoxycarbonyl, or acyl; or R 4  and R 5 , taken together with any intervening atoms, form a heteroaryl ring; 
         R 6  is hydrogen, halo, amino, alkoxy, lower alkyl, cyano, or X when W 1  is CR 6  or CHR 6 ; or R 6  is hydrogen or lower alkyl when W 1  is NR 6 ; 
         R 7  is hydrogen, halo, lower alkyl, or aryl when W 2  is CR 7 ; or R 7  is hydrogen, lower alkyl, or aryl when W 2  is NR 7 ; or R 7  and R 3 , taken together with any intervening atoms, form a cycloalkyl, heterocycloalkyl, or heteroaryl ring; 
         R 8  and R 9  are independently hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl, or R 8  and R 9  taken together with any intervening atoms, form a heterocycloalkyl ring; 
         R 10  is hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; 
         R 11  is hydrogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or X; or R 11  and R 5  taken together with any intervening atoms, form a heterocycloalkyl or heteroaryl ring; and 
         X is —C(O)NR 8 R 9 , —SO 2 NR 8 R 9 , —NHC(O)NR 8 R 9 , or —NR 8 C(O)R 10 . 
       
     
     
         2 .- 59 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.